Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
413 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00153816 | Vitamin D/Calcium Polyp Prevention Study | completed | Phase 2 / Phase 3 | 2,813 | Dartmouth-Hitchcock Medical CenterOTHER | 2 | Mar 15, 2017 | clinicaltrials |
| NCT00003119 | Surgery in Treating Children With Neuroblastoma | completed | Phase 3 | 968 | Children's Oncology GroupNETWORK | 7 | Mar 13, 2017 | clinicaltrials |
| NCT00858871 |
| First Line Hepato Cellular Carcinoma (HCC)(BRISK FL) |
| completed |
| Phase 3 |
| 1,714 |
| Bristol-Myers SquibbINDUSTRY |
| 26 |
| Oct 17, 2016 |
| clinicaltrials |
| NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 2,035 | Hoffmann-La RocheINDUSTRY | 33 | Oct 6, 2016 | clinicaltrials |
| NCT00861614 | Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 988 | Bristol-Myers SquibbINDUSTRY | 27 | Sep 30, 2016 | clinicaltrials |
| NCT00056407 | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk(REDUCE) | completed | Phase 3 | 8,231 | GlaxoSmithKlineINDUSTRY | 42 | Sep 23, 2016 | clinicaltrials |
| NCT01057810 | Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 837 | Bristol-Myers SquibbINDUSTRY | 24 | Aug 18, 2016 | clinicaltrials |
| NCT00002575 | Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer | completed | Phase 3 | 810 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 18, 2016 | clinicaltrials |
| NCT00002716 | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | completed | Phase 3 | 135 | Alliance for Clinical Trials in OncologyOTHER | 4 | Jul 13, 2016 | clinicaltrials |
| NCT00574275 | Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer(VANILLA) | terminated | Phase 3 | 546 | SanofiINDUSTRY | 24 | Jun 7, 2016 | clinicaltrials |
| NCT00486668 | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer | unknown | Phase 3 | 529 | NSABP Foundation IncNETWORK | 3 | Jun 6, 2016 | clinicaltrials |
| NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 627 | Hoffmann-La RocheINDUSTRY | 20 | Apr 1, 2016 | clinicaltrials |
| NCT01151410 | An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age | completed | Phase 3 | 208 | Novartis PharmaceuticalsINDUSTRY | 7 | Mar 7, 2016 | clinicaltrials |
| NCT00305643 | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer | terminated | Phase 3 | 11 | M.D. Anderson Cancer CenterOTHER | 2 | Dec 24, 2015 | clinicaltrials |
| NCT00003906 | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women | completed | Phase 3 | 19,747 | NSABP Foundation IncNETWORK | 3 | Oct 6, 2015 | clinicaltrials |
| NCT01384292 | Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain | terminated | Phase 3 | 14 | AstraZenecaINDUSTRY | 14 | Jun 1, 2015 | clinicaltrials |
| NCT00009906 | Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor | terminated | Phase 3 | 748 | National Cancer Institute (NCI)NIH | 3 | Dec 23, 2014 | clinicaltrials |
| NCT01650805 | Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) | terminated | Phase 3 | 307 | Ariad PharmaceuticalsINDUSTRY | 24 | Nov 17, 2014 | clinicaltrials |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | completed | Phase 3 | 2,067 | Hoffmann-La RocheINDUSTRY | 34 | Sep 30, 2014 | clinicaltrials |
| NCT00059839 | Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma | completed | Phase 3 | 129 | Children's Oncology GroupNETWORK | 5 | Sep 22, 2014 | clinicaltrials |
| NCT01309737 | A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | completed | Phase 3 | 960 | PfizerINDUSTRY | 11 | Sep 19, 2014 | clinicaltrials |
| NCT00003937 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | completed | Phase 3 | 253 | Children's Oncology GroupNETWORK | 6 | Aug 5, 2014 | clinicaltrials |
| NCT00002875 | Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma | completed | Phase 3 | 421 | Children's Oncology GroupNETWORK | 5 | Aug 1, 2014 | clinicaltrials |
| NCT00003093 | Combination Chemotherapy in Treating Children With Neuroblastoma | completed | Phase 3 | 573 | Children's Oncology GroupNETWORK | 7 | Aug 1, 2014 | clinicaltrials |
| NCT00002610 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | completed | Phase 3 | 203 | Children's Oncology GroupNETWORK | 7 | Jul 25, 2014 | clinicaltrials |
| NCT00002618 | Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma | completed | Phase 3 | 242 | Children's Oncology GroupNETWORK | 3 | Jul 24, 2014 | clinicaltrials |
| NCT00499109 | Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | completed | Phase 3 | 275 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 3 | Jul 9, 2014 | clinicaltrials |
| NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | unknown | Phase 3 | 1,200 | University of LeicesterOTHER | 5 | Jun 24, 2014 | clinicaltrials |
| NCT00139841 | Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab | completed | Phase 3 | 103 | CephalonINDUSTRY | 3 | May 9, 2014 | clinicaltrials |
| NCT00507416 | Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone(UPFRONT) | completed | Phase 3 | 502 | Millennium Pharmaceuticals, Inc.INDUSTRY | 2 | May 1, 2014 | clinicaltrials |
| NCT00215943 | Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | terminated | Phase 3 | 90 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Apr 17, 2014 | clinicaltrials |
| NCT00033332 | Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma | completed | Phase 3 | — | National Cancer Institute (NCI)NIH | 3 | Apr 4, 2014 | clinicaltrials |
| NCT00522834 | Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma | terminated | Phase 3 | 630 | Synta Pharmaceuticals Corp.INDUSTRY | 8 | Mar 4, 2014 | clinicaltrials |
| NCT00002995 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | completed | Phase 3 | 483 | Children's Oncology GroupNETWORK | 7 | Feb 14, 2014 | clinicaltrials |
| NCT00003739 | Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy | completed | Phase 3 | 67 | Children's Oncology GroupNETWORK | 7 | Feb 14, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT00005977 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | completed | Phase 3 | 83 | Children's Oncology GroupNETWORK | 6 | Aug 21, 2013 | clinicaltrials |
| NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 34 | Aug 21, 2013 | clinicaltrials |
| NCT00673049 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) | terminated | Phase 3 | 583 | PfizerINDUSTRY | 27 | Jul 24, 2013 | clinicaltrials |
| NCT00003593 | Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome | completed | Phase 3 | 254 | Children's Oncology GroupNETWORK | 7 | Jun 27, 2013 | clinicaltrials |
| NCT00002596 | Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors | completed | Phase 3 | 270 | Memorial Sloan Kettering Cancer CenterOTHER | 4 | Jun 26, 2013 | clinicaltrials |
| NCT00012324 | Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer | completed | Phase 3 | — | Eximias PharmaceuticalINDUSTRY | 3 | Jun 26, 2013 | clinicaltrials |
| NCT00003945 | Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer | completed | Phase 3 | 400 | Gynecologic Oncology GroupNETWORK | 4 | May 27, 2013 | clinicaltrials |
| NCT00451958 | A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | completed | Phase 3 | 386 | Ferring PharmaceuticalsINDUSTRY | 12 | Mar 21, 2013 | clinicaltrials |
| NCT00032084 | S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery | terminated | Phase 3 | 10 | SWOG Cancer Research NetworkNETWORK | 2 | Mar 11, 2013 | clinicaltrials |
| NCT00002593 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed | completed | Phase 3 | 1,135 | SWOG Cancer Research NetworkNETWORK | 4 | Jan 3, 2013 | clinicaltrials |
| NCT00295750 | The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer | completed | Phase 3 | 620 | Ferring PharmaceuticalsINDUSTRY | 12 | Dec 19, 2012 | clinicaltrials |
| NCT00561470 | Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen(VELOUR) | completed | Phase 3 | 1,226 | SanofiINDUSTRY | 28 | Sep 28, 2012 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials